Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis.
Thorax. 2013 Sep 12;
Authors: Keir GJ, Garfield B, Hansell DM, Loebinger MR, Wilson R, Renzoni EA, Wells AU, Maher TM
In sarcoidosis, chronic pulmonary aspergillosis (CPA) may be associated with significant morbidity, and treatment failure rates are often high, even with newer triazole antifungal agents. We report a treatment regimen of cyclical caspofungin infusions in 10 patients with sarcoidosis and worsening CPA despite oral triazoles.
PMID: 24029745 [PubMed - as supplied by publisher]